Shanghai Pharmaceuticals (Germany) Probability of Future Stock Price Finishing Over 10.63

S1R Stock  EUR 1.56  0.01  0.64%   
Shanghai Pharmaceuticals' future price is the expected price of Shanghai Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Shanghai Pharmaceuticals Holding performance during a given time horizon utilizing its historical volatility. Check out Shanghai Pharmaceuticals Backtesting, Shanghai Pharmaceuticals Valuation, Shanghai Pharmaceuticals Correlation, Shanghai Pharmaceuticals Hype Analysis, Shanghai Pharmaceuticals Volatility, Shanghai Pharmaceuticals History as well as Shanghai Pharmaceuticals Performance.
  
Please specify Shanghai Pharmaceuticals' target price for which you would like Shanghai Pharmaceuticals odds to be computed.

Shanghai Pharmaceuticals Target Price Odds to finish over 10.63

The tendency of Shanghai Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over € 10.63  or more in 90 days
 1.56 90 days 10.63 
close to zero percent
Based on a normal probability distribution, the odds of Shanghai Pharmaceuticals to move over € 10.63  or more in 90 days from now is close to zero percent (This Shanghai Pharmaceuticals Holding probability density function shows the probability of Shanghai Stock to fall within a particular range of prices over 90 days) . Probability of Shanghai Pharmaceuticals price to stay between its current price of € 1.56  and € 10.63  at the end of the 90-day period is about 18.17 .
Assuming the 90 days horizon Shanghai Pharmaceuticals has a beta of 0.64. This usually implies as returns on the market go up, Shanghai Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Shanghai Pharmaceuticals Holding will be expected to be much smaller as well. Additionally Shanghai Pharmaceuticals Holding has an alpha of 0.4925, implying that it can generate a 0.49 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Shanghai Pharmaceuticals Price Density   
       Price  

Predictive Modules for Shanghai Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Shanghai Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.081.564.76
Details
Intrinsic
Valuation
LowRealHigh
0.081.524.72
Details

Shanghai Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Shanghai Pharmaceuticals is not an exception. The market had few large corrections towards the Shanghai Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Shanghai Pharmaceuticals Holding, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Shanghai Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.49
β
Beta against Dow Jones0.64
σ
Overall volatility
0.11
Ir
Information ratio 0.14

Shanghai Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Shanghai Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Shanghai Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Shanghai Pharmaceuticals may become a speculative penny stock
Shanghai Pharmaceuticals had very high historical volatility over the last 90 days
About 22.0% of the company outstanding shares are owned by corporate insiders

Shanghai Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Shanghai Stock often depends not only on the future outlook of the current and potential Shanghai Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Shanghai Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.8 B

Shanghai Pharmaceuticals Technical Analysis

Shanghai Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Shanghai Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Shanghai Pharmaceuticals Holding. In general, you should focus on analyzing Shanghai Stock price patterns and their correlations with different microeconomic environments and drivers.

Shanghai Pharmaceuticals Predictive Forecast Models

Shanghai Pharmaceuticals' time-series forecasting models is one of many Shanghai Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Shanghai Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Shanghai Pharmaceuticals

Checking the ongoing alerts about Shanghai Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Shanghai Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Shanghai Pharmaceuticals may become a speculative penny stock
Shanghai Pharmaceuticals had very high historical volatility over the last 90 days
About 22.0% of the company outstanding shares are owned by corporate insiders

Other Information on Investing in Shanghai Stock

Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.